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Although the human sebaceous gland can synthesize
cholesterol from acetate and can further metabolize
steroids such as dehydroepiandrosterone into potent an-
drogens, the de novo production of steroids from choles-
terol has not been demonstrated in human skin. The
goal of this study was to delineate the steroidogenic
pathway upstream from dehydroepiandrosterone by
documenting the presence of members of the P450 side
chain cleavage system (P450scc). This system catalyzes
the initial step in steroid hormone synthesis following
translocation of cholesterol to the inner mitochondrial
membrane. In concert with its cofactors, adrenodoxin
and adrenodoxin reductase, and the transcription factor
steroidogenic factor 1, P450scc converts cholesterol
to pregnenolone. An SV40 immortalized human se-
baceous gland cell line (SEB-1) was established in order
to facilitate investigation of the P450scc system. The se-
baceous phenotype of SEB-1 sebocytes was con¢rmed
using immunohistochemistry, Oil Red O staining, and
gene array expression analysis. Presence of P450scc,
adrenodoxin reductase, cytochrome P450 17-hydroxy-
lase (P450c17), and steroidogenic factor 1was documen-
ted in human facial skin, human sebocytes, and SEB-1
sebocytes. Using immunohistochemistry, antibodies to
the above proteins localized to epidermis, hair follicles,
sebaceous ducts, and sebaceous glands in sections of fa-
cial skin. Results of immunohistochemistry were con-
¢rmed with Western blotting. Biochemical activity of
cytochrome P450scc and P450c17 was demonstrated in
SEB-1 sebocytes using radioimmunoassay. The relative
abundance of mRNA for P450scc, P450c17, and steroi-
dogenic factor 1 in SEB-1 sebocytes and sebaceous
glands was compared to mRNA levels in ovarian theca
and granulosa cells using real-time quantitative poly-
merase chain reaction. Gene array expression analysis
and quantitative polymerase chain reaction indicated
that mRNA for P450scc is more abundant than mRNA
for both P450c17 and steroidogenic factor 1 in sebaceous
glands and SEB-1 cells. These data demonstrate that the
skin is in fact a steroidogenic tissue. The clinical signi¢-
cance of this ¢nding in mediating androgenic skin dis-
orders such as acne, hirsutism, or androgenetic alopecia
remains to be established. Key words: acne/cholesterol/
sebaceous gland/sebocyte/steroid. J Invest Dermatol 120:
905 ^914, 2003
S
teroidogenic tissues are de¢ned by their ability to con-
vert cholesterol into pregnenolone via the P450 side
chain cleavage enzyme (P450scc). The transfer of
cholesterol to the inner mitochondrial membrane and
its conversion to pregnenolone marks the rate-limiting
step in steroidogenesis. Classic steroidogenic tissues include the
adrenal gland, ovary, and testis. Although certain endocrine tar-
get tissues such as the skin are capable of metabolizing sex steroid
precursors into potent androgens, they are not considered steroi-
dogenic tissues because of the lack of evidence supporting the ex-
pression and activity of P450scc. Local metabolism of steroid
hormones within endocrine tissues is currently recognized as an
important principle in the cell-type- and tissue-speci¢c regula-
tion of hormone action (Zouboulis, 2000). In this regard, it is
essential to delineate the steroidogenic pathway in human skin
in order to understand how locally produced hormones regulate
the growth and di¡erentiation of human epidermis, hair, and se-
baceous glands.
The skin and sebaceous glands are capable of synthesizing cho-
lesterol de novo from acetate (Cassidy et al, 1986; Proksch et al, 1992;
Smythe et al, 1998). Although this cholesterol is utilized in cell
membranes and in the formation of the epidermal barrier, and is
secreted in sebum, its use as a substrate for steroid hormone
synthesis has not been established. In order for steroid synthesis
to occur, cholesterol needs to be translocated from the outer to
the inner mitochondrial membrane. This process is regulated by
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the steroidogenic acute regulatory protein (StAR) and a func-
tional homolog MLN 64 (Sugawara et al, 1995;Watari et al, 1997).
Cytochrome P450scc is encoded by the CYP11a gene. This en-
zyme is located on the inner mitochondrial membrane in proxi-
mity to its cofactors adrenodoxin reductase and adrenodoxin
(Black et al, 1993). Adrenodoxin reductase is a £avoprotein that
accepts electrons from reduced nicotinamide adenine dinucleo-
tide phosphate and then transfers them to an iron sulfur protein,
adrenodoxin, which in turn passes electrons on to P450scc. Adre-
nodoxin reductase and adrenodoxin serve as generic electron
transport proteins for all mitochondrial forms of cytochrome
P450. The cytochrome P450 17-hydroxylase (P450c17) catalyzes
both 17a-hydroxylase and 17, 20-lyase activities and is encoded
by the CYP17 gene. The 17a-hydroxylase reaction leads to con-
version of pregnenolone to 17-hydroxypregnenolone, which is
converted to the androgen precursor dehydroepiandrosterone by
the 17, 20-lyase. P450c17 is active in the production of androgens
in the adrenal gland and ovary and is linked to the development
of polycystic ovary syndrome (Rosen¢eld et al, 1990), a condition
that is often associated with acne, androgenetic alopecia, and/or
hirsutism. The steroidogenic factor 1 (SF-1) is an orphan nuclear
receptor that regulates steroidogenic genes including P450scc,
P450c17, StAR, adrenocorticotrophic hormone receptor, 3b-hy-
droxysteroid dehydrogenase, 17b-hydroxysteroid dehydrogenase,
and aromatase (Parker and Schimmer, 1997). SF-1 is in part re-
sponsible for the tissue-speci¢c expression of these genes. It plays
a pivotal role in the maintenance of di¡erentiated function and
steroidogenic capacity in steroidogenic cells of the adrenal cortex
and gonads. SF-1 expression has recently been described in
human skin where it is speculated to play a role in cutaneous
steroidogenesis (Patel et al, 2001).
Immortalized human sebaceous gland cell lines have been va-
luable in the study of sebaceous gland physiology and endocri-
nology (Zouboulis et al, 1999; 2002; Fritsch et al, 2001).We have
developed and characterized a new human sebaceous gland cell
line, SEB-1, via transfection of human sebocytes with SV40 large
T antigen (Zouboulis et al, 1999). SEB-1 sebocytes are a valuable
model for the study of steroidogeinc enzyme expression and ac-
tivity. In this paper we demonstrate that the essential enzymes
and cofactors in the steroidogenic cascade are present in human
skin, secondary cultures of human sebocytes, and SEB-1 sebo-
cytes, thus providing a rationale for subsequent investigation to
determine the functional signi¢cance of this pathway in andro-
gen-mediated diseases of the skin.
MATERIALS AND METHODS
Sebocyte culture Human facial skin was obtained from facial surgeries
under a protocol approved by the Institutional Review Board of the
Pennsylvania State University College of Medicine. Human sebaceous
glands were dissected from facial skin and sebocyte cultures were
established. Cells were plated with mitomycin-C-inactivated 3T3
¢broblasts in Dulbecco’s modi¢ed Eagle’s medium (DMEM)/Ham’s F-12
3 : 1, fetal bovine serum 5%, adenine 1.8  10^4 M, hydrocortisone 0.4
mg per ml, insulin 5 mg per ml, epidermal growth factor 10 ng per ml,
cholera toxin 1.2  10^10 M, and antibiotics (100 ) containing
keratinocyte growth factor 10 ng per ml (Xia et al, 1989; Thiboutot et al,
2000).
Establishment and characterization of SEB-1 sebocytes Secondary
sebocyte cultures were established as above from glands from normal skin
from the preauricular area of a 55-y-old male. Cells were transfected with a
DNA construct containing the sequence encoding the transforming SV40
large T protein with a CMV promoter (gift, Dr. Satir Tevethia) using a
standard gene transfer technique with Lipofectin reagent (GibcoBRL)
(Zouboulis et al, 1999). The cell line (SEB-1) was derived using standard
clonal dilution techniques on passage 9 cells. Successful transformation
of sebocytes was con¢rmed in eighth passage cells by localization of
SV40 large T antigen in the nucleus of transformed cells using immuno-
histochemistry and continued passage in culture. Karyotyping was per-
formed in the Clinical Cytogenetics Laboratory at the Pennsylvania
State University on passage 15 cells. Colony forming e⁄ciency was
determined by plating 500 cells per plate in triplicate, staining plates with
hematoxylin after 5 d, and counting colonies under a light microscope.
Population doubling time was calculated by plating 500 cells per well in
triplicate followed by manual cell counts at days 2, 4, 8, 12, 16, 20, 24, and
28. Sebaceous phenotype of SEB-1 cells was veri¢ed by con¢rmation of
lipid droplets with Oil Red O staining and by immunohistochemical
localization of 5a-reductase, sebaceous gland antigen (OM-1), and
cytokeratins 4, 7, and 13. Further veri¢cation of expression of these and
other proteins in SEB-1 sebocytes and comparison with expression in
isolated human sebaceous glands was achieved using gene array expression
analysis as described below. All experiments utilizing SEB-1 sebocytes in
this paper were performed on passage 23 cells.
Other tissues and cells JEG-3 cells, a human choriocarcinoma cell line,
H295R cells, a human adrenocortical carcinoma cell line, and Y-1 cells,
derived from a mouse adrenocortical carcinoma, were obtained from
American Tissue Culture Collection, Rockville, MD. These cells were
utilized as positive controls for the immunohistochemistry and Western
blotting. Human theca and granulosa cells were isolated and cultured in
the laboratories of Drs McAllister and Strauss as previously described and
used as controls in the quantitative polymerase chain reaction (QPCR)
experiments (Nelson et al, 2001). Of note is that the theca cells were
stimulated to express steroidogenic enzymes by growth in the presence of
forskolin and the granulosa cells were obtained from ovaries that had been
stimulated by gonadotrophins.
Gene array expression analysis Gene array expression analysis was
performed on total RNA from SEB-1 cells and isolated human sebaceous
glands in order to verify expression of steroidogenic enzymes, cofactors,
and transcription factors and to obtain a relative comparison of the levels
of expression of these genes. In addition, the array databases was scanned
for characteristic sebaceous gland proteins and lipogenic enzymes. Gene
array expression analysis of total RNA isolated from human sebaceous
glands and SEB-1 cells was performed using the GeneChip Expression
Analysis System (A¡ymetrix, Santa Clara, CA) using the human gene
chip (U95Av2). Total RNA was prepared from isolated human sebaceous
glands and from cells grown to con£uence and maintained for 3 d in
standard medium skin using RNeasyTotal RNA Isolation KitR (Qiagen,
Chatsworth, CA). Three separate RNA isolations and expression analyses
were performed for SEB-1 sebocytes and two RNA isolations and
expression analyses were performed from human sebaceous glands.
Quality of the RNA was veri¢ed by analysis of a test chip containing
probe arrays from the 50 end, 30 end, and middle portion of housekeeping
genes such as b-actin and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). Total RNAwas reverse transcribed to cDNA and then cRNA,
which was fragmented and hybridized to the gene chip array; the array was
scanned according to the A¡ymetrix protocol. The amount of light
emitted at 570 nm is proportional to the bound cRNA target at each
location on the probe array. The average signal intensity for each probe set
is a relative indicator of the level of expression of the transcript. Triplicate
data from SEB-1 cells and duplicate data from sebaceous glands were
compared using a paired t test generated using the A¡ymetrix Data
Mining Tool SoftwareR version 3.0 (A¡ymetrix). The array analysis was
then copied to a Microsoft Excel ¢le and scanned for the genes of
interest, which include steroidogenic enzymes, cofactors, and genes
involved in lipid metabolism.
Antibodies Nuclear expression of SV40 large T antigen in SEB-1 cells
was con¢rmed with a mouse monoclonal antibody for SV40 T antigen
derived from B6 mice injected with Pab 901 cells (gift, Dr. Satir Tevethia).
A mouse monoclonal antibody to the type 1 5a-reductase (gift, Dr. Ellen
Bayne) was used at a dilution of 10 mg per ml (Bayne et al, 1999). The
sebaceous gland antigen OM-1 is a characteristic marker for sebaceous
glands. A mouse monoclonal antibody to OM-1 (gift, Dr. M. Palatsides)
was used in a dilution of 1 : 1000. Mouse monoclonal antibodies
to keratins 4, 7, and 13 were purchased from Sigma (St. Louis, MO) and
each used in a dilution of 1 : 100 in immunohistochemistry. Polyclonal
rabbit antihuman antibodies to P450scc, adrenodoxin reductase, and
adrenodoxin were a generous gift from Dr. Walter Miller (Black et al,
1993) The antibody to P450c17 was generated in the laboratory of Dr. Jan
McAllister to full-length human recombinant P450c17 (Jabara et al, 2002).
The antibody to P450scc was used in immunohistochemistry in a dilution
of 1 : 100. The antibodies to adrenodoxin reductase and adrenodoxin were
each used in immunohistochemistry in a dilution of 1 : 2000 and the
P450c17 antibody was used in a dilution of 1 : 350. Polyclonal rabbit
antimouse SF-1 was purchased from Upstate Biotechnology, Lake Placid,
NY. The SF-1 antibody was used as a 1 : 500 dilution for human facial
skin and cultured cells in immunohistochemistry.
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Immunohistochemistry and Oil Red O staining Veri¢cation
of transfection of secondary sebocytes was con¢rmed with immuno-
histochemistry with SV40 antibody. Positive controls for this experiment
included a section of brain from a mouse expressing SV40. Negative
controls consisted of secondary sebocytes that were not transfected with
SV40 and SEB-1 sebocytes that were incubated without primary SV40
antibody. Expression of characteristic sebaceous gland proteins in SEB-1
cells was determined using immunohistochemistry with antibodies to the
OM-1 sebaceous gland antigen, 5a-reductase type 1, and cytokeratins 4, 7,
and 13. Oil Red O staining for intracellular lipids was performed.
Facial skin from ¢ve subjects (males and females) was embedded in
mounting medium and serial frozen sections were taken for reaction with
antibodies to P450scc, adrenodoxin reductase, adrenodoxin, P450c17, and
SF-1. Sections were ¢xed in cold acetone for 20 min. Primary cultures of
human sebocytes and passage 22 cultures of SEB-1 sebocytes were
subcultured to a chamber slide system (Nalge Nunc International,
Naperville, IL) for use in immunohistochemistry. Cells were grown both
in the presence and absence of serum to determine if the presence of serum
altered steroidogenic enzyme expression. Con£uent cells were ¢xed in
100% ethanol. Negative controls consisted of sections incubated with
nonimmune serum in place of the primary antibody. Immunoperoxidase
reaction was carried out using the avidinbiotin complex method (ABC
kit, Vector Laboratories, Burlingame, CA). Endogenous peroxidase was
blocked via incubation in the presence of hydrogen peroxide. 3, 3-
Diaminobenzidine tetrachloride was used as the precipitating substrate for
localization of peroxidase activity. Cells were counterstained with
hematoxylin in some experiments.
Biochemical activity of P450scc and P450c17 Biochemical activity of
P450scc and P450c17 was assayed in SEB-1 sebocytes by radioimmunoassay
(Black et al, 1993). In two separate experiments, cells were grown in their
standard medium in 100 mm plates until colonies reached 80%
con£uence, at which time 10 mm forskolin was added to the medium of
half of the plates to stimulate adenylate cyclase release, which in turn
induces steroidogenic enzyme activity. After 72 h, medium was switched
to a serum-free medium containing DMEM : Ham’s F-12 1 : 1, bovine
serum albumin 0.4%, transferrin 0.1 mg per ml, 20 nm selenium, 1 mm
vitamin E, and antibiotics with or without 10 mm forskolin. 22-
Hydroxycholesterol (Sigma) was chosen as a substrate as it readily
traverses the mitochondrial membrane without reliance on the StAR. As
a result, it can achieve a su⁄cient substrate concentration within the inner
mitochondrial membrane in order to assay the activity of P450scc. 22-
Hydroxycholesterol was added to each plate in a ¢nal concentration of 5
mm. Medium (6 ml) was removed from triplicate plates for each time
point and cells were counted using a hemocytometer at times 0, 3 h,
10 h, 48 h, and 72 h in order to examine the time course of
17a-hydroxypregnenolone production. Media samples and 17a-
hydroxypregnenolone standards were extracted twice with ethyl ether,
evaporated to dryness, and each reconstituted in a 500 ml volume.
Duplicate samples (200 ml each) were then incubated with anti-17-
hydroxypregnenolone antiserum and [3H]-17a-hydroxypregnenolone
(both from ICN Biomedicals, Carson, CA) for 16 h at 41C (Black et al,
1993). Unbound hydroxypregenolone was adsorbed with charcoal and
centrifuged at 3000g for 15 min at 41C. The supernatant was counted in a
liquid scintillation counter. Counts were plotted on a standard curve and
the concentration of 17a-hydroxypregnenolone was determined. Data were
normalized to cell count and are reported as the mean 7 SEM picograms
hydroxypregnenolone per 106 cells of three experiments.
Western blotting Protein extracts of control cells (JEG-3, H295R,Y-1,
ovarian theca cells), human sebaceous glands, and SEB-1 sebocytes were
prepared using methods previously described (Thiboutot et al, 2000;
Jabara et al, 2002). Acrylamide gels (10%) were prepared and run
according to the method of Laemmli (Laemmli, 1970). The identi¢cation
of the apparent molecular weight of the proteins on sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) to which the
antibodies bound was carried out by protein blot analysis. The
nitrocellulose membrane was incubated with P450scc (1 : 500),
adrenodoxin reductase (1 : 200), adrenodoxin (1 : 200), SF-1 (1 : 1000), or
P450c17 (1 : 5000). For Western blotting of SF-1, immunoprecipitation
with the SF-1 antibody was done on cell lysates of JEG-3 cells and
human sebaceous glands. Lysates were diluted in phosphate-bu¡ered
saline (PBS) to a concentration of approximately 1 mg per ml total cell
protein. For P450scc, adrenodoxin reductase, and SF-1, the protein
recognized by antibody was revealed as dark purple bands using a 1 : 5000
dilution of horseradish peroxidase linked goat antirabbit IgG (Sigma) and
4-chloro-1-naphthol (0.05%) and hydrogen peroxide (0.05%) in a mixture
of bu¡er and methanol as a chromogen. For P450c17, a chemiluminescence
detection system was utilized as previously described (Jabara et al, 2002).
Real-time QPCR Additional veri¢cation of the expression of P450scc,
P450c17, and SF-1 in SEB-1 sebocytes and isolated human sebaceous glands
was obtained using real-time QPCR. RNA was isolated from SEB-1
sebocytes, sebaceous glands, and ovarian theca and granulosa cells. Of
note is that the theca cells were used as a positive control in these
experiments. The granulosa cells were obtained from ovaries that had
been stimulated by gonadotrophins. These cells served as a negative
control for the P450c17 experiments as these cells do not express
signi¢cant levels of this enzyme. Theca and granulosa cells were grown in
the presence of forskolin in order to enhance steroidogenic enzyme
expression. SEB-1 sebocytes and sebaceous glands were not treated with
forskolin prior to RNA isolation. Total RNA (1^5 mg) was treated with
RQ1 RNase-free DNase (Promega, Madison, WI) for 30 min at 371C
before reverse transcription with Moloney murine leukemia virus reverse
transcriptase (Promega) as described by the manufacturer. The resulting
cDNAwas diluted 10-fold in sterile water and aliquots were subjected to
quantitative real-time PCR. PCR primer pairs and probes for the analysis
were designed with the Primer Express 1.5 software that accompanies the
Applied Biosystems Model 7700 sequence detector (Perkin Elmer Life
Sciences).
The SYBR Green reagent was used to detect amplicons of the
human P450scc cDNA (forward, TGGGTCGCCTATCACCAGTAT bases
420^440; reverse, CCACCCGGTCTTTCTTCCA bases 501^483),
human P450c17 (forward, TGCTTATTAAGAAGGGCAAGGACTT bases
295^319; reverse, TGTTGGACGCGATGTCTAGAGT bases 363^342),
and human SF-1 (forward, GAGCATGCAGGCCAAGGA; reverse,
CATTTCGATGAGCAGGTTGTTG). Primer concentrations for each
target cDNA were determined empirically. Agarose gel electrophoresis
and analysis of the multicomponent data for all samples using the
Dissociation Curves 1.0 program (Perkin Elmer) indicated the presence of
a single PCR product. To account for di¡erences in starting material, the
human GAPDH primers and probe reagents from Applied Biosystems
were used. The experimental and GAPDH PCR were carried out in
separate tubes in triplicate. The relative amounts of experimental and
GAPDH PCR products were determined by comparison to a standard
curve generated by serial dilution of a sample (normal theca cell RNA)
containing high levels of the target amplicons that was also run in
triplicate (Jabara et al, 2002). The average of the experimental triplicate was
divided by the average of the GAPDH triplicate and the resulting
normalized values were used for statistical analysis. Unpaired t tests were
used to compare the normalized levels of each of the target genes with
values obtained in each of the other cell types. A probability value less
than 0.05 was considered signi¢cant.
RESULTS
SEB-1 sebocytes persist in culture and express genes
involved in lipid metabolism Successful transformation of
human sebocytes was con¢rmed by continued passage in culture
and by immunohistochemistry with an antibody to SV40 largeT
antigen (Fig 1). Karyotyping revealed aneuploid cells with
chromosome numbers ranging from 60 to 65. SEB-1 sebocytes
have a mean (7SD) colony forming e⁄ciency of 67% 7 4.8%.
Logarithmic growth occurred between days 2 and 14 with a
population doubling time of 36 h. Immunohistochemistry
reveals cytoplasmic localization of characteristic sebaceous gland
proteins such as 5a-reductase, sebaceous gland antigen, and
cytokeratins 4, 7, and 13 (Fig 2, K4 data not shown). Oil Red O
staining con¢rmed the presence of cytoplasmic lipid droplets
(Fig 2F).
Further con¢rmation of the sebaceous phenotype of SEB-1
sebocytes was obtained by comparing gene expression in total
RNA from human sebaceous glands with expression in total
RNA from SEB-1 sebocytes using gene array expression
analysis. Array data from three experiments with RNA from
SEB-1 sebocytes and two experiments with RNA from human
sebaceous glands were normalized for signal intensity and
compared using a t test (a¼ 0.05) by the A¡ymetrix data
mining tool analysis software. The analyzed array was scanned
for genes characteristic of sebaceous glands including those
involved in lipid metabolism and steroid metabolism.
Representative genes and their presence or absence call as
determined by the A¡ymetrix software are presented in
Table I. Of note is that the di¡erences in signal intensity
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Figure1. SEB-1 sebocytes are stably transfected with SV40 largeTantigen. Panel a: Negative control; SEB-1 sebocytes, no primary antibody. Panel b:
Positive control; mouse brain tumor expresses SV40 antigen. Panel c: Human sebocytes prior to transfection do not express SV40 antigen (negative control).
Panel d: SEB-1 sebocytes express SV40 antigen in the nucleus. Bar: 100 mM.
Figure 2. SEB-1 sebocytes express proteins characteristic of human sebaceous glands. Panel a: Negative control; SEB-1 sebocytes, no primary anti-
body. Panels be: SEB-1 sebocytes exhibit cytoplasmic expression of type 1 5a-reductase (panel b), cytokeratin 7 (panel c), cytokeratin 13 (panel d), and OM-1
sebaceous gland antigen (panel e). Panel f: SEB-1 sebocytes exhibit cytoplasmic lipid droplets with Oil Red O staining (arrow). Bar: 100 mM.
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between SEB-1 sebocytes and sebaceous glands were not
statistically signi¢cant for each of the genes listed, indicating
that there were no signi¢cant di¡erences in expression of these
genes.
Antibodies to P450scc, P450c17, adrenodoxin reductase, and
SF-1 localize in human facial skin, secondary sebocytes,
and SEB-1 sebocytes Antibodies to P450scc, P450c17, and
adrenodoxin reductase localized in sebaceous glands, sebaceous
ducts, and hair follicles in sections of human facial skin (Fig 3).
Prominent immunolocalization was noted in the more
di¡erentiated layers of the epidermis with each of these
antibodies (Fig 4). Antibodies to P450scc, P450c17, and
adrenodoxin reductase localized to the cytoplasm of cultured
sebocytes and SEB-1 sebocytes, whereas SF-1 exhibited
perinuclear or nuclear localization (Figs 4, 5). There were no
di¡erences in the pattern of expression in cells cultured under
serum-free conditions (data not shown).
SEB-1 cells convert 22-hydroxycholesterol to 17-hydro-
xypregnenolone The biochemical conversion of 22-hydroxy-
cholesterol to 17-hydroxypregnenolone requires the activity of
the P450scc and P450c17 enzymes. When SEB-1 cells were
incubated with 22-hydroxycholesterol in the presence and
absence of 10 mm forskolin, production of low levels of 17-
hydroxypregnenolone (less than 6 pmol per 106 cells) was noted
over time using radioimmunoassay. (Fig 6). Levels of 17-
hydroxypregnenolone in forskolin-treated cells were on the
order of 1.5^3.3-fold higher compared to untreated cells. Using
a paired t test, the di¡erence between forskolin-treated and
untreated cells was signi¢cant at 48 h (p ¼ 0.03, a¼0.05)
indicating an increase in enzyme activity in response to
increased levels of adenylate cyclase.
Western analysis con¢rms the presence of the P450scc,
P450c17, adrenodoxin reductase, and SF-1 proteins in
extracts of human sebaceous glands or SEB-1 sebocytes A
52 kDa band corresponding to the P450scc peptide was noted in
extracts of Y-1 cells and theca cells (positive controls),
human sebaceous glands, and SEB-1 sebocytes (theca and
SEB-1 data shown, Fig 7a). When extracts of ovarian theca
cells (positive control) and SEB-1 sebocytes were incubated
with antibody to P450c17, a band of approximately 60 kDa
was noted corresponding to P450c17 (Fig 7b). Follow-
ing immuno-precipitation of antibody, a 53 kDa band
corresponding to the SF-1 peptide was recognized in extracts of
sebaceous glands and JEG-3 cells (positive control) (Fig 7). A 48
kDa band corresponding to the adrenodoxin reductase peptide
was noted in extracts of JEG-3 cells (positive control) and
sebaceous glands (Fig 7d). Western blot analysis failed to
con¢rm the presence of adrenodoxin in sebaceous gland extracts
(data not shown).
Gene array expression analysis detects mRNA for P450scc
and adrenodoxin reductase but not for P450c17,
adrenodoxin, or SF-1 mRNA for P450scc and adrenodoxin
reductase were detected in SEB-1 sebocytes and sebaceous
glands using gene array expression analysis (Table I). No
statistically signi¢cant di¡erences in signal intensity were noted
in the level of expression of these genes between these two
tissues using the t test within the Data Mining Tool Software.
The signal intensities for adrenodoxin and SF-1 in SEB-1 cells
and sebaceous glands, however, did not reach the threshold of
detection set by the A¡ymetrix software in order to call the
genes ‘‘present’’. The analysis software determined that P450c17
was ‘‘marginally present’’ in SEB-1 cells and ‘‘absent’’ in
sebaceous glands.
Relative abundance of mRNA for P450scc, P450c17, and SF-
1 di¡ers in sebaceous glands and SEB-1 cells compared to
ovarian theca and granulosa cells Using real-time QPCR
with the SYBR Green reagent, mRNA for P450scc, P450c17,
and SF-1 was detected in SEB-1 cells and sebaceous glands
and compared to levels found in ovarian theca and granulosa
cells (Fig 8). These assays were not performed for adreno-
doxin or adrenodoxin reductase. The relative abundance of
transcripts for P450scc, P450c17, and SF-1 in RNA isolated
from sebaceous glands, SEB-1 sebocytes, and ovarian theca
and granulosa cells was determined in separate experiments
for each target gene. Relative £uorescence units obtained
from samples from each tissue were normalized to levels
obtained with primers to GAPDH and compared to a standard
curve generated using normal theca RNA. The mRNA
for P450scc was most abundant in SEB-1 sebocytes
(relative abundance 35,800 units) with increases of 6-fold,
4-fold, and 7-fold compared to sebaceous glands, theca cells,
and granulosa cells, respectively. Using a two-sample t test
(a¼ 0.05), the di¡erences between SEB-1 sebocytes and the
other tissues were each statistically signi¢cant (po0.05). mRNA
for P450c17 was most abundant in ovarian theca cells with
increases of 11-fold compared to SEB-1 sebocytes (p ¼ 0.009),
22-fold compared to sebaceous glands (p¼ 0.002), and 550-fold
compared to granulosa cells (p ¼ 0.006). mRNA for SF-1 was
least abundant in SEB-1 sebocytes, being 32-fold less compared
to sebaceous glands and theca cells (po0.01) and 6-fold less than
granulosa cells (po0.01).
Table I. Gene array expression analysis of RNA from SEB-1 sebocytes and sebaceous glands
Calle
Type Gene GenBank # SEB-1 Sebaceous glands
Lipid metabolism Fatty acid synthase U29344 P P
Fatty acid desaturase AF002668 P P
Medium chain acyl CoA dehydrogenase M91432 P P
Squalene synthase X69141 P P
Farnesyl transferase L10413 P P
Steroid metabolism 5a-Reductase type 1 M32313 P P
3b -Hydroxysteroid dehydrogenase M38180 P P
P450scc M14565 P P
Adrenodoxin reductase J03826 P P
Adrenodoxin M23668 A A
P450c17 M31153 M A
SF-1 U76388 A A
aThe A¡ymetrixR software makes a call as to whether genes are present (P), absent (A), or marginal (M).
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DISCUSSION
Delineation of the steroid hormone biosynthetic pathway in the
skin is an essential step in advancing our understanding of how
androgens mediate both the physiology and pathophysiology of
the skin. This information has particular relevance to androgen-
mediated diseases of the skin such as acne, androgenetic alopecia,
and hirsutism wherein the potential exists for local enzyme inhi-
bition as a therapeutic intervention. Steroidogenic tissues are de-
¢ned as those tissues that are capable of converting cholesterol
into pregnenolone. Classical steroidogenic tissues include the
adrenal gland and the gonads. Other sites such as the placenta,
brain, and intestine can synthesize steroids from cholesterol. The
skin, however, has not been considered to be a steroidogenic tis-
sue because the presence and activity of the enzymes such as
P450scc and P450c17 have not been de¢nitively demonstrated.
The metabolic pathways upstream and downstream from preg-
nenolone synthesis have been demonstrated in the skin, however.
For example, the epidermis and sebaceous glands are able to
synthesize cholesterol from two-carbon fragments such as acetate
(Cooper et al, 1976; Cassidy et al, 1986). Whether this locally
synthesized cholesterol is used as a substrate for steroidogenesis
is not known. Downstream in the steroid metabolic pathway, ac-
tivity of each of the enzymes needed to convert dehydroepian-
drosterone into potent androgens and estrogens has been
demonstrated in the epidermis, hair follicle, and sebaceous gland
(Baillie et al, 1965; Hay and Hodgins, 1978; Itami and Takayasu,
1981; Sawaya et al, 1988; Dumont et al, 1992; Thiboutot et al, 1995;
1998; Zouboulis et al, 2000; Fritsch et al, 2001). These enzymes in-
clude 3b -hydroxysteroid dehydrogenase, 17b-hydroxysteroid de-
hydrogenase, 5a-reductase, and aromatase. The missing data in
the pathway from acetate to potent sex steroids is demonstration
of the conversion of cholesterol to pregnenolone by P450scc and
subsequent conversion of pregnenolone to 17-hydroxypregneno-
lone and on to dehydroepiandrosterone by P450c17. There are
data to suggest that the cytochrome P450 enzymes that are in-
volved in steroidogenesis are present in the skin. mRNAs for
P450scc, P450c17, and 11-hydroxylase were previously detected
Figure 3. P450scc, P450c17, adrenodoxin reductase, and SF-1 are expressed in human facial skin. Antibodies were reacted with cryostat sections of
human facial skin. Panel a: Negative control; human skin, no primary antibody. Panel b: Antibody to P450scc. Panel c: Antibody to P450c17. Panel d: Antibody
to adrenodoxin reductase. Panel e: Antibody to SF-1. Localization of each antibody was noted in epidermis (short arrow), sebaceous duct (thin arrow), and
sebaceous gland (long arrow). Bar: 100 mM.
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Figure 4. Secondary cultures of human sebocytes express P450scc, P450c17, adrenodoxin reductase, and SF-1. Antibodies were reacted with
secondary cultures of human facial sebocytes. Panel a: Negative control; secondary sebocytes, no primary antibody. Panel b: Antibody to P450scc. Panel c:
Antibody to P450c17. Panel d: Antibody to adrenodoxin reductase. Panel e: Antibody to SF-1. Cytoplasmic localization of P450scc, P450c17, and adrenodoxin
was noted. Antibody to SF-1 (panel e) exhibited perinuclear localization. Bar: 100 mM.
Figure 5. SEB-1 sebocytes express P450scc, P450c17, adrenodoxin reductase, and SF-1. Antibodies were reacted with SEB-1 sebocytes. Panel a:
Negative control; SEB-1 sebocytes, no primary antibody. Panel b: Antibody to P450scc. Panel c: Antibody to P450c17. Panel d: Antibody to adrenodoxin
reductase. Panel e: Antibody to SF-1. Cytoplasmic localization of P450scc, P450c17, and adrenodoxin was noted. Antibody to SF-1 exhibited perinuclear
and nuclear localization. Bar: 100 mM.
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in human skin using reverse transcriptase PCR (Slominski et al,
1996). Expression of P450c17, adrenodoxin, and P450scc has been
demonstrated in human epidermis using immunohistochemistry
with antibodies directed against the rat proteins; however, no lo-
calization of P450scc was noted in sebaceous glands (Venencie
et al, 1999). Using immunohistochemistry with antibodies direc-
ted against the human proteins, we have demonstrated that
P450scc, P450c17, adrenodoxin, and SF-1 are expressed in the epi-
dermis and sebaceous glands of human skin, in secondary cul-
tures of human sebocytes, and in an immortalized human
sebaceous gland cell line (SEB-1).
Biochemical assay is a means of demonstrating an enzyme’s
functionality. The performance of biochemical assays, however,
requires the availability of large numbers of cells. Human sebo-
cytes in culture have a limited growth potential due to their rapid
di¡erentiation as evidenced by the accumulation of cytoplasmic
lipids and cell rupture. For this reason, large numbers of cells
cannot be obtained in order to perform the replicates needed for
biochemical assays. Immortalization of human sebocytes with
SV40 antigen has allowed intensive investigation and advance-
ment in our understanding of sebaceous gland physiology and
endocrinology (Zouboulis et al, 1999; 2002; Fritsch et al, 2001). In
this paper we describe the establishment and preliminary charac-
terization of an immortalized human sebaceous gland cell line
(SEB-1) derived from the facial skin of a 55-y-old male. SEB-1
cells persist in culture, maintain a sebaceous phenotype, and ex-
press steroidogenic proteins, cofactors, and transcription factors as
evidenced by immunohistochemistry andWestern blot. Most im-
portantly, SEB-1 cells demonstrate functionality of the P450scc
system via biochemical conversion of 22-hydroxycholesterol to
17-hydroxypregnenolone. The suitability of SEB-1 sebocytes as
a model for steroidogenesis in sebaceous glands was con¢rmed
by parallel experiments performed using human skin, secondary
cultures of human sebocytes, and human sebaceous glands.
During the course of our investigation, certain discrepancies in
the data were noted particularly with data generated using the re-
latively new technique of gene array expression analysis. For ex-
ample, the expression of the cofactor adrenodoxin was noted in
human skin, secondary sebocytes, and SEB-1 sebocytes using im-
munohistochemistry, yet its expression was not con¢rmed by
Western blotting or gene array expression analysis. A more sensi-
tive methodology such as reverse transcriptase PCR is required to
determine if low levels of adrenodoxin transcripts are present in
SEB-1 sebocytes or sebaceous glands. It seems likely that adreno-
doxin would be present as this cofactor is required for biochem-
ical activity of the P450scc, which was in fact demonstrated in
SEB-1 sebocytes. Gene array expression analysis also failed to
Figure 6. Radioimmunoassay of SEB-1 sebocytes reveals activity of
the P450scc and P450c17 enzymes and response to forskolin. SEB-1
sebocytes were incubated with 22-hydroxycholesterol in the presence
(Fþ ) and absence (F) of 10 mM forskolin. Samples were assayed at time
0, 3 h, 10 h, and 48 h. Data were normalized to cell counts performed at
each time point. Levels of 17-hydroxypregnenolone in forskolin-treated
cells were on the order of 1.5^3.3-fold higher compared to untreated cells.
Using a paired t test, the di¡erence between forskolin-treated and untreated
cells was signi¢cant at 48 h (p ¼ 0.03, a¼0.05) indicating an increase in
enzyme activity in response to increased levels of cyclic AMP resulting
from treatment with forskolin.
Figure 7. Western blot analyses of sebaceous gland and SEB-1 ex-
tracts con¢rm expression of P450scc, P450c17, and adrenodoxin re-
ductase. Panel a: P450scc. Lane M, molecular weight markers; lanes A, B, 52
kDa bands corresponding to P450scc are noted in extracts of theca cells
(lane A) and SEB-1 cells (lane B). Panel b: P450c17. Lane M, molecular
weight markers; lanes A, B, 60 kDa bands corresponding to P450c17 are
noted in extracts of theca cells (lane A) and SEB-1 cells (lane B). Panel c:
SF-1. Lane M, molecular weight markers; lanes A, B, 53 kDa bands corre-
sponding to SF-1 are noted in sebaceous glands (lane A) and JEG-3 cells
(lane B). Panel d: Adrenodoxin reductase. Lane M, molecular weight mar-
kers; lanes A, B, bands of 48 kDa are noted in JEG-3 cells (lane A) and se-
baceous glands (lane B).
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detect mRNA for SF-1 in sebaceous glands and SEB-1 sebocytes.
P450c17 was marginally present in SEB-1 cells, and absent in se-
baceous gland RNA. These messages were detected, however,
using the more sensitive method of QPCR. As there is no ampli-
¢cation step in gene array expression analysis, it is possible that
mRNA for SF-1 and P450c17 is in lower abundance in sebaceous
glands and sebocytes compared to transcripts for P450scc and
adrenodoxin reductase. Alternatively, the oligonucleotide probe
pairs for these genes on the array may not yield su⁄cient discri-
mination to allow for detection of these genes.
Once we determined that a functional P450scc system exists in
SEB-1 sebocytes, we were interested in comparing the level of
gene expression and biochemical activity of these enzymes with
other known steroidogenic tissues such as ovarian theca cells. The
excess production of androgens by theca cells is linked to poly-
cystic ovary disease, a condition that can be accompanied by acne,
hirsutism, and/or androgenetic alopecia. Using real-time QPCR,
signi¢cant di¡erences in message abundance of steroidogenic en-
zymes were noted between ovarian cells and sebaceous glands
and SEB-1 sebocytes. The mRNA for P450scc in SEB-1 sebo-
cytes was 4-fold higher in than ovarian theca cells, which had
been stimulated with forskolin. In contrast, mRNA for P450c17
was most abundant in ovarian theca cells with an 11-fold increase
compared to SEB-1 sebocytes and a 22-fold increase compared to
sebaceous glands.
It is important to discern whether di¡erences in message abun-
dance correlate with di¡erences in the biochemical activity of
steroidogenic enzymes at the protein level and whether biochem-
ical activity of these enzymes is clinically signi¢cant. In ovarian
stromal cells, for example, mRNA for P450scc and P450c17 is de-
tected using real-time QPCR, yet biochemical assay fails to de-
monstrate activity of these enzymes (Jabara et al, 2002). Ovarian
theca cells express steroidogenic enzymes and demonstrate func-
tionality of P450c17 through conversion of progesterone to
hydroxyprogesterone. Normal theca cells produce on average
60^300 pmol 17-hydroxyprogesterone per 106 cells after 72 h in
culture without the addition of exogenous substrate when grown
in the presence of forskolin (Nelson et al, 1999). In contrast,
although SEB-1 sebocytes respond to forskolin with an approxi-
mate 2-fold increase in hydroxypregnenolone synthesis, sebo-
cytes produce only 0.008 pmol 17-hydroxypregnenolone per 106
cells after 72 h when provided with hydroxycholesterol as a sub-
strate. These data indicate that the activity of P450scc, P450c17, or
both is markedly lower in SEB-1 cells compared to theca cells.
It is curious why SEB-1 sebocytes have a 4-fold increase in the
abundance of mRNA for P450scc compared to forskolin-stimu-
lated theca cells, yet the biochemical conversion of cholesterol
into 17-hydroxypregnenolone is markedly lower in SEB-1 sebo-
cytes. On the other hand, mRNA for P450c17 is more abundant
in theca cells compared to SEB-1 sebocytes. Gene array expres-
sion analysis suggests that P450c17 expression is lower than
P450scc expression in SEB-1 sebocytes.Taken together, it is likely
that the production of 17-hydroxypregnenolone in SEB-1 cells
may be limited by the activity of the P450c17 rather than
P450scc. Alternatively, 17-hydroxypregnenolone may be rapidly
metabolized in SEB-1 sebocytes to downstream products. Addi-
tional biochemical assays are required to test this hypothesis.
Several mechanisms may be important in regulating steroido-
genesis in the sebaceous gland. Enzyme activity can be regulated
in a site-speci¢c fashion by substrate availability or by the expres-
sion of transcription factors. It is possible that sebaceous glands
may preferentially utilize dehydroepiandrosterone from the ser-
um as a source of more potent androgen synthesis rather than
synthesizing steroids de novo from endogenous or circulating
sources of cholesterol. SF-1 and DAX are transcriptional regula-
tors of steroidogenesis whose expression has been documented in
sebaceous glands (Patel et al, 2001). The expression of StAR,
P450scc, P450c17, and other enzymes is induced by SF-1 and re-
pressed by DAX (Parker and Schimmer, 1997). SF-1 is an impor-
tant transcriptional regulator of P450scc in the adrenal and
gonads. Our study con¢rms the localization of SF-1 in whole
skin and documents the expression of SF-1 in sebaceous glands
and SEB-1 sebocytes. mRNA for SF-1was most abundant in se-
baceous glands and theca cells and least abundant (on the order of
300-fold less) in SEB-1 sebocytes. Despite the decreased level of
SF-1 expression in SEB-1 sebocytes, these cells expressed in-
creased levels of P450scc compared to the other cell types. These
data suggest that SF-1 may not be an important regulator of
P450scc gene expression in these cells. This is in concordance
with the observation that P450scc activity is still present in the
placenta and intestine of SF-1 knockout mice, suggesting that
SF-1 may not regulate enzyme expression in these sites (Keeney
et al, 1995; Parker and Schimmer, 1997). Additional experiments
are needed to determine if SF-1 regulates transcription of steroi-
dogenic enzymes in the skin.
Figure 8. QPCR reveals signi¢cant di¡erences in message abun-
dance for steroidogenic enzymes in SEB-1 sebocytes, sebaceous
glands, and ovarian theca and granulosa cells. Reverse transcription
was performed on one sample of SEB-1 sebocyte RNA, one sample of
sebaceous gland RNA, three samples of theca cell RNA, and three samples
of granulosa cell RNA. QPCR was performed in triplicate from each
cDNA.The cycle thresholds for each reaction were determined and plotted
against a standard curve derived using normal theca RNA where relative
£uorescence units were assigned to each point on the standard curve. Re-
lative £uorescence values were normalized for GAPDH and compared be-
tween tissues using an unpaired t test (a¼ 0.05). The numbers above each
bar represent the relative £uorescence units. Panel a: Relative abundance of
mRNA for P450scc was determined. Levels in SEB-1 sebocytes are signif-
icantly greater than in other tissues (po 0.05 for each comparison). Panel b:
Relative abundance of P450c17 mRNA was determined. Levels in theca
cells are signi¢cantly greater than those in SEB-1 sebocytes (p ¼ 0.009),
sebaceous glands (p ¼ 0.007), and granulosa cells (p ¼ 0.006). Panel c: Re-
lative abundance of mRNA for SF-1was determined. Levels in SEB-1 se-
bocytes are signi¢cantly less than those in other cell types (po 0.01).
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It has been suggested that human skin can function as an inde-
pendent peripheral endocrine organ with the expression of ster-
oidogenic enzymes, melanocortins, insulin-like growth factors
and binding proteins, and corticotrophin releasing hormone
(Slominski et al, 1995; Zouboulis, 2000; Zouboulis et al, 2002).
Apart from demonstration of 17, 20-lyase activity, the ¢nding of
P450scc and P450c17 expression and activity in sebaceous glands
in this study completes the biochemical pathway from acetate
through potent androgens. These data suggest that the skin may
be capable of de novo synthesis of androgens and other steroids
from cholesterol or its precursors. The challenge will come in de-
termining the functional signi¢cance of this pathway in normal
and diseased skin and in determining whether selective local in-
terruption of this pathway can be of therapeutic bene¢t in andro-
gen-mediated diseases of the skin.
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